Commonwealth Equity Services
KYNB

Commonwealth Equity Services’s Kyntra Bio KYNB Stock Holding History

Commonwealth Equity Services’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-422
Closed -$3K – 4285
2025
Q1 		$3K Buy
+422
New +$5.06K ﹤0.01% 4170
2021
Q2 		– Sell
-261
Closed -$226K – 3545
2021
Q1 		$226K Hold
261
– – ﹤0.01% 3028
2020
Q4 		$242K Hold
261
– – ﹤0.01% 2757
2020
Q3 		$268K Sell
261
-7
-3% -$7.53K ﹤0.01% 2466
2020
Q2 		$271K Buy
268
+3
+1% +$2.79K ﹤0.01% 2351
2020
Q1 		$230K Buy
265
+4
+2% +$3.98K ﹤0.01% 2263
2019
Q4 		$280K Hold
261
– – ﹤0.01% 2373
2019
Q3 		$241K Hold
261
– – ﹤0.01% 2430
2019
Q2 		$295K Buy
+261
New +$286K ﹤0.01% 2211

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Commonwealth Equity Services's KYNB Position: Q2 2025 in Review

Commonwealth Equity Services sold out of Kyntra Bio (KYNB) in Q2 2025, closing a stake of 422 shares — an estimated $3K sold.

Commonwealth Equity Services first reported a position in KYNB in Q2 2019 and held it in 9 quarters. The position peaked at $295K in Q2 2019. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.

  • Commonwealth Equity Services reported no remaining Kyntra Bio position as of Q2 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 422 Kyntra Bio shares in Q2 2025, an estimated $3K.
  • Commonwealth Equity Services first reported a position in Kyntra Bio in Q2 2019 and held it in 9 quarters.
  • Commonwealth Equity Services's Kyntra Bio position peaked at $295K in Q2 2019.
  • 30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.

Based on Commonwealth Equity Services's 13F filing for Q2 2025, filed 6 Aug 2025.